Ricerca
Una lista di farmaci condivisa per la pediatria territoriale di famiglia: uno studio osservazionale
A list of shared drugs for paediatric outpatients: an observational study
Daniele Piovani, Antonio Clavenna, Maurizio Bonati E Il Gruppo Pefab*
Dipartimento di Salute Pubblica, Laboratorio per la salute materno-infantile, IRCCS - Istituto di Ricerche Farmacologiche
Mario Negri, Milano
*I componenti del Gruppo PeFAB sono riportati nel Box in chiusura dellarticolo.
Maggio 2014 - pagg. 315 -321
Abstract
Objectives - To identify a list of shared drugs on the basis of those prescribed by a group
of paediatricians during the daily clinical practice. The group were involved in initiatives
concerning health care for years.
Materials and methods - A total of 64 paediatricians operating in 4 local health units (LHUs) of the Lombardy region participated in the study by collecting information about all the pharmacological prescription filled during 8 weeks (April, 2 - June, 1 2012). The percentage of paediatricians prescribing the same drug was calculated for all active substances. Commonly used drugs were included in the list of shared drugs if: they were prescribed by ! 50%; ! 50% of the prescriptions were filled by recommendation of a specialist and the drug was prescribed by ! 25% of the paediatricians.
Results - Systemic antibiotics (43.8% of packages), anti-asthmatics (12.9%) and antihistamines (11.8%) were the most prescribed classes. A total of 381 active substances were prescribed. The most prescribed drug was amoxicillin (25.8% of packages), followed by amoxicillin clavulanate (9.2%) and cetirizine (9.0%). About 30% of the prescribed packages were generic and the most prescribed formulation was oral solution (54.6%). The most recommended drug by the specialist was valproic acid. The list of shared drug was composed of 38 active substances belonging to 16 therapeutic subgroups and covering 83.1% of the prescribed packages. Of these drugs, 33 were shared by ! 50% of the paediatricians while 5 were mainly recommended by the specialist.
Conclusions - A list of shared drugs used during the daily clinical practice was identified on the basis of the frequency of use and sharing among paediatricians. The list could be propaedeutic to the creation of a shared formulary of commonly used paediatric drugs, also taking into account cost-effectiveness and safety in order to improve the rational use of drugs in children.
Materials and methods - A total of 64 paediatricians operating in 4 local health units (LHUs) of the Lombardy region participated in the study by collecting information about all the pharmacological prescription filled during 8 weeks (April, 2 - June, 1 2012). The percentage of paediatricians prescribing the same drug was calculated for all active substances. Commonly used drugs were included in the list of shared drugs if: they were prescribed by ! 50%; ! 50% of the prescriptions were filled by recommendation of a specialist and the drug was prescribed by ! 25% of the paediatricians.
Results - Systemic antibiotics (43.8% of packages), anti-asthmatics (12.9%) and antihistamines (11.8%) were the most prescribed classes. A total of 381 active substances were prescribed. The most prescribed drug was amoxicillin (25.8% of packages), followed by amoxicillin clavulanate (9.2%) and cetirizine (9.0%). About 30% of the prescribed packages were generic and the most prescribed formulation was oral solution (54.6%). The most recommended drug by the specialist was valproic acid. The list of shared drug was composed of 38 active substances belonging to 16 therapeutic subgroups and covering 83.1% of the prescribed packages. Of these drugs, 33 were shared by ! 50% of the paediatricians while 5 were mainly recommended by the specialist.
Conclusions - A list of shared drugs used during the daily clinical practice was identified on the basis of the frequency of use and sharing among paediatricians. The list could be propaedeutic to the creation of a shared formulary of commonly used paediatric drugs, also taking into account cost-effectiveness and safety in order to improve the rational use of drugs in children.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Clavenna A, Bonati M. Drug prescriptions
to outpatient children: a review of the literature.
Eur J Clin Pharmacol 2009;65:749-55.
2. Cartabia M, Campi R, Clavenna A, et al. Geographical
epidemiology of antibacterials in
the preschool age. Int J Health Geogr 2012;
11:52.
3. Piovani D, Clavenna A, Cartabia M, Bonati
M. The regional profile of antibiotic prescriptions
in Italian outpatient children. Eur J Clin
Pharmacol 2012;68:997-1005.
4. Clavenna A, Sequi M, Bonati M. Drug prescribing
by Italian family paediatricians: an exception?
Acta Paediatr 2010;99:754-7.
5. Garattini S. Are me-too drugs justified? J
Nephrol 1997;10:283-94.
6. Gagne JJ, Choudhry NK. How many metoo
drugs is too many? JAMA 2011;305:711-2.
7. Clavenna A, Sequi M, Bortolotti A, Fortino
I, Merlino L, Bonati M. Farmaci essenziali e
attitudini prescrittive dei pediatri. Medico e
Bambino 2010;29:565-9.
8. Essential Medicines List for Children,
World Health Organization, 4rd edition, 2013
available online at: http://www.who.int/medicines/
publications/essentialmedicines/4th_
EMLc_FINAL_ web_ 8Jul13.pdf.
9. Laing R, Waning B, Gray A, Ford N, t Hoen
E. 25 years of the WHO essential medicines
lists: progress and challenges. Lancet 2003;
361:1723-9.
10. World Health Organization. WHO Medicines
Strategy 2008-2013, Draft 8 http://
www.who.int/medicines/publications/Medicines_
Strategy_draft08-13.pdf, 12 February
2013.
11. Chinburapa V, Larson LN, Brucks M,
Draugalis J, Bootman JL, Puto CP. Physician
prescribing decisions: the effects of situational
involvement and task complexity on information
acquisition and decision making. Soc
Sci Med 1993;36:1473-82.
12. Bjerrum L, Bergman U. Wide variation in
the number of different drugs prescribed by
general practitioners. A prescription database
study. Scand J Prim Health Care 2000;18:94-8.
13. Reidenberg MM. Can the selection and
use of essential medicines decrease inappropriate
drug use? Clin Pharmacol Ther 2009;
85:581-3.
14. Campi R, Garattini L, Cazzato T, et al. Pharmacoeconomics
analysis of prescription in
Italian pediatric general practice. Giornale
Italiano di Farmacia Clinica 2001;15:30-5.
15. Sturkenboom MC, Verhamme KM, Nicolosi
A, et al; TEDDY European Network of
Excellence. Drug use in children: cohort
study in three European countries. BMJ 2008;
337:a2245.
16. Cazzato T, Pandolfini C, Campi R, Bonati
M; ACP Puglia-Basilicata Working Group.
Drug prescribing in out-patient children in
Southern Italy. Eur J Clin Pharmacol 2001;57:
611-6.
17. Iommarini A, Sequi M, Cartabia M, et al.
Prescrizione di antibiotici equivalenti nella popolazione
pediatrica in Lombardia. Medico e
Bambino 2013;32:173-8.
18. Fabiano V, Mameli C, Cattaneo D, et al.
Perceptions and patterns of use of generic
drugs among Italian family pediatricians: first
round results of a web survey. Health Policy
2012;104:247-52.
19. Piovani D, Clavenna A, Sequi M, et al. on
behalf of the PeFAB group. Reducing the
costs of paediatric antibiotic prescribing in the
community by implementing guideline recommendations.
J Clin Pharm Ther 2013;38:
373-8.
20. Constipation in children and young people:
NICE guidance available, disponibile online:
http://guidance.nice.org.uk/CG99/NICEGuid
ance/pdf/English.
21. van Asperen Peter P, Mellis CM, Sly PD;
Thoracic Society of Australia and New
Zealand. The role of corticosteroids in the
management of childhood asthma. Med J
Aust 2002;176:168-73.
22. Bacharier LB, Boner A, Carlsen KH, et al.;
European Pediatric Asthma Group. Diagnosis
and treatment of asthma in childhood: a
PRACTALL consensus report. Allergy 2008;
63:5-34.
23. Principi N, Bianchini S, Baggi E, Esposito
S. No evidence for the effectiveness of systemic
corticosteroids in acute pharyngitis,
community-acquired pneumonia and acute
otitis media. Eur J Clin Microbiol Infect Dis
2013;32:151-60.
Corrispondenza: daniele.piovani@marionegri.it